Product Dossier
VAGIFEM
Product Dossier for VAGIFEM (estradiol, Novo Nordisk Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novo Nordisk Pharmaceuticals
- Active ingredient: estradiol
- Therapeutic area: Reproductive Health
- Related brand: ESTRADOT
- Related brand: Estraderm MX
- Related brand: FEMOSTON
- Same area: PROVERA
- Same area: BEMFOLA
What it is VAGIFEM is an estradiol 10 microgram modified release pessary .
Approved indications
— Vaginal atrophy in postmenopausal women .
PBS listing
VAGIFEM 10 microgram pessary (modified release) is listed on the PBS as an unrestricted item with an ex-manufacturer price of A$15.40 .
Regulatory history
VAGIFEM was first registered on the ARTG on 19 October 2010 . In November 2017, the PBAC recommended an amendment to the PBS listing to allow estradiol vaginal tablets to be used for the treatment of vaginal atrophy in postmenopausal women .